The Technical Analyst
Select Language :
Conformis Inc [CFMS]

Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices

Conformis Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Conformis Inc is listed at the  Exchange

0.44% $2.27

America/New_York / 1 sep 2023 @ 15:57


FUNDAMENTALS
MarketCap: 17.88 mill
EPS: -5.70
P/E: -0.398
Earnings Date: Oct 30, 2023
SharesOutstanding: 7.88 mill
Avg Daily Volume: 0.157 mill
RATING 2023-09-14
B
Neutral
RATINGS
Rating CashFlow: Buy
Return On Equity: Strong Sell
Return On Asset: Strong Sell
DE: Strong Buy
P/E: Neutral
Price To Book: Sell
QUARTER GROWTHS
1/222/223/224/221/232/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.398 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
0.00x
Company: PE -0.398 | industry: PE 222.16
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 2.24 - 2.28

( +/- 0.97%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-09-05 Desrochers Christine Sell 81 465 Common Stock
2023-09-05 Augusti Mark A Buy 17 778 Common Stock
2023-09-05 Augusti Mark A Sell 190 277 Common Stock
2023-09-05 Bienkowski Carrie Sell 19 909 Common Stock
2023-09-05 Fischetti Gary P Sell 10 470 Common Stock
INSIDER POWER
37.01
Last 95 transactions
Buy: 11 050 651 | Sell: 1 697 895

Forecast: 01:40 - $2.51

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $2.27 (0.44% )
Volume 0.0071 mill
Avg. Vol. 0.157 mill
% of Avg. Vol 4.51 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Conformis Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Conformis Inc

RSI

Intraday RSI14 chart for Conformis Inc

Last 10 Buy & Sell Signals For CFMS

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Conformis Inc

CFMS

Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruciate retaining total knee replacement product; iTotal PS, a posterior stabilized knee replacement product, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also provides Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.

Last 10 Buy Signals

Date Signal @
ARUSDMar 29 - 04:28$41.19
KCSUSDMar 29 - 04:24$11.87
FTNUSDMar 29 - 04:141.819
ORAIUSDMar 29 - 04:0814.59
IONUSDMar 29 - 04:08452.00
MXUSDMar 29 - 04:07$4.21
RETHUSDMar 29 - 04:043 905.62
ABTUSDMar 29 - 04:041.978
XU100.ISMar 29 - 04:03PTS9 101.28
DYDXUSDMar 29 - 04:003.39

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.